Current Endoscopic Management of Achalasia Cardia: Review Article

Author's Information:

Kumar H.R. (MBBS, MS)

Associate Professor of Surgery, Taylor University School of Medicine and Health Science, 47500 Subang Jaya, Malaysia

Taylor’s University School of Medicine Clinical Campus,4700 Sg Buloh, Selangor, Malaysia.

Vol 2 No 11 (2025):VOLUME 02 ISSUE 11 NOVEMBER 2025

Page No.: 91-96

Abstract:

The management of achalasia cardia can be categorized into endoscopic and surgical approaches. Endoscopic management encompasses pneumatic dilatation and botulinum toxin injection. Additionally, peroral endoscopic myotomy is included within endoscopic therapy, although some scholars have classified it under surgical therapy for achalasia. Surgical management involves the implementation of Heller myotomy and esophagectomy. In this review, we will examine the role of botulinum toxin, pneumatic dilatation, and peroral endoscopic myotomy in the management of achalasia cardia, focusing on their indications and associated complications.

KeyWords:

Achalasia, Botulinum toxin, Endoscopy, Medical, Pneumatic dilatation, POEM.

References:

  1. Annese, V., Bassotti, G., Coccia, G., Dinelli, M., D'Onofrio, V., Gatto, G., Leandro, G., Repici, A., Testoni, P. A., & Andriulli, A. (2000). A multicenter randomized study of intrasphincteric botulinum toxin in patients with oesophageal achalasia. GISMAD Achalasia Study Group. Gut46(5), 597–600. https://doi.org/10.1136/gut.46.5.597
  2. Aiolfi, A., Bona, D., Riva, C. G., Micheletto, G., Rausa, E., Campanelli, G., Olmo, G., Bonitta, G., & Bonavina, L. (2020). Systematic review and Bayesian network meta-analysis comparing laparoscopic Heller myotomy, pneumatic dilatation, and peroral endoscopic myotomy for esophageal Achalasia. Journal of Laparoendoscopic and Advanced Surgical Techniques, 30(2), 1–9. https://doi.org/10.1089/lap.2019.0432
  3. Aljebreen, A. M., Samarkandi, S., Al-Harbi, T., Al-Radhi, H., & Almadi, M. A. (2014). Efficacy of pneumatic dilatation in Saudi achalasia patients. Saudi Journal of Gastroenterology, 20(1), 43–47. https://doi.org/10.4103/1319-3767.126317
  4. Allaix, M. E., & Patti, M. G. (2015). Endoscopic Dilatation, Heller Myotomy, and Peroral Endoscopic Myotomy: Treatment Modalities for Achalasia. In Surgical Clinics of North America (Vol. 95, Issue 3, pp. 567–578). W.B. Saunders. https://doi.org/10.1016/j.suc.2015.02.009
  5. Bechara, R., Ikeda, H., & Inoue, H. (2015). Peroral endoscopic myotomy: An evolving treatment for Achalasia. In Nature Reviews Gastroenterology and Hepatology (Vol. 12, Issue 7, pp. 410–426). Nature Publishing Group. https://doi.org/10.1038/nrgastro.2015.87
  6. Boeckxstaens, G. E. E. (2007). Achalasia. Best Practice and Research in Clinical Gastroenterology, 21(4), 595–608. https://doi.org/10.1016/j.bpg.2007.03.004
  7. Bonifácio, P., De Moura, D. T. H., Bernardo, W. M., De Moura, E. T. H., Farias, G. F. A., Neto, A. C. M., Lordello, M., Korkischko, N., Sallum, R., & De Moura, E. G. H. (2019). Pneumatic dilation versus laparoscopic Heller’s myotomy in the treatment of Achalasia: Systematic review and meta-analysis based on randomized controlled trials. In Diseases of the Esophagus (Vol. 32, Issue 2). Oxford University Press. https://doi.org/10.1093/dote/doy105
  8. Bredenoord, A. J., Rösch, T., & Fockens, P. (2014). Peroral endoscopic myotomy for achalasia. Neurogastroenterology and Motility, 26(1), 3–12. https://doi.org/10.1111/nmo.12257
  9. Costantini, M., & Costantini, A. (2026). Clinical Evaluation, Etiology and Classification of Esophageal Achalasia (pp. 147–155). https://doi.org/10.1007/978-3-031-90570-4_17
  10. Cuilliere, C., Ducrotte, P., Zerbib, F., Metman, E. H., De Looze, D., Guillemot, F., Hudziak, H., Lamouliatte, H., Grimaud, J. C., Ropert, A., Dapoigny, M., Bost, R., Lemann, M., Bigard, M. A., Denis, P., Auget, J. L., Galmiche, J. P., & Bruley Des Varannes, S. (1997). Achalasia: outcome of patients treated with intrasphincteric injection of botulinum toxin. In Gut (Vol. 41).
  11. Dirks, R. C., Kohn, G. P., Slater, B., Whiteside, J., Rodriguez, N. A., Docimo, S., Pryor, A., & Stefanidis, D. (2021). Is peroral endoscopic myotomy (POEM) more effective than pneumatic dilation and Heller myotomy? A systematic review and meta-analysis. In Surgical Endoscopy (Vol. 35, Issue 5, pp. 1949–1962). Springer. https://doi.org/10.1007/s00464-021-08353-w
  12. Dobrowolsky, A., & Fisichella, P. M. (2014). The management of esophageal achalasia: From diagnosis to surgical treatment. In Updates in Surgery (Vol. 66, Issue 1, pp. 23–29). https://doi.org/10.1007/s13304-013-0224-1
  13. Drexel, S., Kishawi, S., & Marks, J. (2020). Peroral Esophageal Myotomy. In Surgical Clinics of North America (Vol. 100, Issue 6, pp. 1183–1192). W.B. Saunders. https://doi.org/10.1016/j.suc.2020.08.004
  14. Eckardt, V. F., Gockel, I., & Bernhard, G. (2004). Pneumatic dilation for achalasia: Late results of a prospective follow up investigation. Gut, 53(5), 629–633. https://doi.org/10.1136/gut.2003.029298
  15. Familiari, P., Greco, S., Volkanovska, A., Gigante, G., Cali, A., Boškoski, I., & Costamagna, G. (2015). Achalasia: Current treatment options. In Expert Review of Gastroenterology and Hepatology (Vol. 9, Issue 8, pp. 1101–1114). Taylor and Francis Ltd. https://doi.org/10.1586/17474124.2015.1052407
  16. Ghoshal, U. C., Rangan, M., & Misra, A. (2012). Pneumatic dilation for achalasia cardia: Reduction in lower esophageal sphincter pressure in assessing response and factors associated with recurrence during long-term follow-up. Digestive Endoscopy, 24(1), 7–15. https://doi.org/10.1111/j.1443-1661.2011.01159.x
  17. Heddle, R., & Cock, C. (2020). Role of botulinum toxin injection in the treatment of achalasia. In Annals of Esophagus (Vol. 3). AME Publishing Company. https://doi.org/10.21037/aoe-2019-ach-09
  18. Howard, J. M., Mongan, A. M., Manning, B. J., Byrne, P., Lawler, P., Ravi, N., & Reynolds, J. V. (2010). Outcomes in achalasia from a surgical unit where pneumatic dilatation is first-line therapy. Diseases of the Esophagus, 23(6), 465–472. https://doi.org/10.1111/j.1442-2050.2010.01055.x
  19. Hulselmans, M., Vanuytsel, T., Degreef, T., Sifrim, D., Coosemans, W., Lerut, T., & Tack, J. (2010). Long-term Outcome of Pneumatic Dilation in the Treatment of Achalasia. Clinical Gastroenterology and Hepatology, 8(1), 30–35. https://doi.org/10.1016/j.cgh.2009.09.020
  20. Inoue, H., Sato, H., Ikeda, H., Onimaru, M., Sato, C., Minami, H., Yokomichi, H., Kobayashi, Y., Grimes, K. L., & Kudo, S. E. (2015). Per-Oral Endoscopic Myotomy: A Series of 500 Patients. Journal of the American College of Surgeons, 221(2), 256–264. https://doi.org/10.1016/j.jamcollsurg.2015.03.057
  21. Katsinelos, P., Kountouras, J., Paroutoglou, G., Beltsis, A., Zavos, C., Papaziogas, B., Elsevier, K. M., & Mimidis, K. (2005). Long-term results of pneumatic dilation for achalasia: A 15 years’ experience. World J Gastroenterol, 11(36), 5701–5705. www.wjgnet.comhttp://www.wjgnet.com/1007-9327/11/5701.asp
  22. Kohn, G. P., Dirks, R. C., Ansari, M. T., Clay, J., Dunst, C. M., Lundell, L., Marks, J. M., Molena, D., Rooker, C., Saxena, P., Swanstrom, L., Wong, R. K., Pryor, A. D., & Stefanidis, D. (2021). SAGES guidelines for the use of peroral endoscopic myotomy (POEM) for the treatment of achalasia. Surgical Endoscopy, 35(5), 1931–1948. https://doi.org/10.1007/s00464-020-08282-0
  23. Leyden, J. E., Moss, A. C., & Macmathuna, P. (2014). Endoscopic pneumatic dilation versus botulinum toxin injection in the management of primary achalasia. In Cochrane Database of Systematic Reviews (Vol. 2014, Issue 12). John Wiley and Sons Ltd. https://doi.org/10.1002/14651858.CD005046.pub3
  24. Martínek, J., Siroký, M., Plottová, Z., Bures, J., Hep, A., & Spicák, J. (2003). Treatment of patients with achalasia with botulinum toxin: a multicenter prospective cohort study. Diseases of the esophagus: official journal of the International Society for Diseases of the Esophagus16(3), 204–209. https://doi.org/10.1046/j.1442-2050.2003.00329.x
  25. Mikaeli, J., Fazel, A., Montazeri, G., Yaghoobi, M., & Malekzadeh, R. (2001). Randomized controlled trial comparing botulinum toxin injection to pneumatic dilatation for the treatment of achalasia. Alimentary pharmacology & therapeutics15(9), 1389–1396. https://doi.org/10.1046/j.1365-2036.2001.01065.x
  26. Miranda-García, P., Casals-Seoane, F., Gonzalez, J. M., Barthet, M., & Santander-Vaquero, C. (2017). Per-oral endoscopic myotomy (POEM): A new endoscopic treatment for achalasia. In Revista Espanola de Enfermedades Digestivas (Vol. 109, Issue 10, pp. 719–726). ARAN Ediciones S.A. https://doi.org/10.17235/reed.2017.4732/2016
  27. Müller, M., Keck, C., Eckardt, A. J., Werling, S., Wehrmann, T., König, J., & Gockel, I. (2018). Outcomes of pneumatic dilation in achalasia: Extended follow-up of more than 25 years with a focus on manometric subtypes. Journal of Gastroenterology and Hepatology (Australia), 33(5), 1067–1074. https://doi.org/10.1111/jgh.14044
  28. Neubrand, M., Scheurlen, C., Schepke, M., & Sauerbruch, T. (2002). Long-term results and prognostic factors in the treatment of achalasia with botulinum toxin. Endoscopy34(7), 519–523. https://doi.org/10.1055/s-2002-33225
  29. Oude Nijhuis, R. A. B., Zaninotto, G., Roman, S., Boeckxstaens, G. E., Fockens, P., Langendam, M. W., Plumb, A. A., Smout, A. J. P. M., Targarona, E. M., Trukhmanov, A. S., Weusten, B. L. A. M., & Bredenoord, A. J. (2020). European Guideline on Achalasia – UEG and ESNM recommendations. In United European Gastroenterology Journal (Vol. 8, Issue 1, pp. 13–34). SAGE Publications Ltd. https://doi.org/10.1177/2050640620903213
  30. Pandolfino, J. E., & Gawron, A. J. (2015). Achalasia: A systematic review. JAMA - Journal of the American Medical Association, 313(18), 1841–1852. https://doi.org/10.1001/jama.2015.2996
  31. Pasricha, P. J., Ravich, W. J., Hendrix, T. R., Sostre, S., Jones, B., & Kalloo, A. N. (1995). Intrasphincteric botulinum toxin for the treatment of achalasia. The New England journal of medicine332(12), 774–778. https://doi.org/10.1056/NEJM199503233321203
  32. Ramchandani, M., Reddy, D. N., Darisetty, S., Kotla, R., Chavan, R., Kalpala, R., Galasso, D., Lakhtakia, S., & Rao, G. V. (2016). Peroral endoscopic myotomy for achalasia cardia: Treatment analysis and follow up of over 200 consecutive patients at a single center. Digestive Endoscopy, 28(1), 19–26. https://doi.org/10.1111/den.12495
  33. Ramzan, Z., & Nassri, A. B. (2013). The role of Botulinum toxin injection in the management of achalasia. In Current Opinion in Gastroenterology (Vol. 29, Issue 4, pp. 468–473). https://doi.org/10.1097/MOG.0b013e328362292a
  34. Riccio, F., Costantini, M., & Salvador, R. (2022). Esophageal Achalasia: Diagnostic Evaluation. World Journal of Surgery, 46(7), 1516–1521. https://doi.org/10.1007/s00268-022-06483-3
  35. Richards, W. O., Torquati, A., & Lutfi, R. (2005). The current treatment of achalasia. Advances in surgery39, 285–314. https://doi.org/10.1016/j.yasu.2005.04.002
  36. Richter, J. E. (2013). Esophageal motility disorder: achalasia. In Current Opinion in Otolaryngology and Head and Neck Surgery (Vol. 21, Issue 6, pp. 535–542). https://doi.org/10.1097/MOO.0b013e3283658f4f
  37. Stavropoulos, S. N., Desilets, D. J., Fuchs, K. H., Gostout, C. J., Haber, G., Inoue, H., Kochman, M. L., Modayil, R., Savides, T., Scott, D. J., Swanstrom, L. L., & Vassiliou, M. C. (2014). Per-oral endoscopic myotomy white paper summary. Gastrointestinal Endoscopy, 80(1), 1–15. https://doi.org/10.1016/j.gie.2014.04.014
  38. Talukdar, R., Inoue, H., & Reddy, D. N. (2015). Efficacy of peroral endoscopic myotomy (POEM) in the treatment of achalasia: a systematic review and meta-analysis. Surgical Endoscopy, 29(11), 3030–3046. https://doi.org/10.1007/s00464-014-4040-6
  39. Tuset, J. A., Luján, M., Huguet, J. M., Canelles, P., & Medina, E. (2009). Endoscopic pneumatic balloon dilation in primary achalasia: Predictive factors, complications, and long-term follow-up. Diseases of the Esophagus, 22(1), 74–79. https://doi.org/10.1111/j.1442-2050.2008.00874.x
  40. Vaezi, M. F., Pandolfino, J. E., & Vela, M. F. (2013). ACG clinical guideline: Diagnosis and management of achalasia. American Journal of Gastroenterology, 108(8), 1238–1249. https://doi.org/10.1038/ajg.2013.196
  41. van Hoeij, F. B., Prins, L. I., Smout, A. J. P. M., & Bredenoord, A. J. (2019). Efficacy and safety of pneumatic dilation in achalasia: A systematic review and meta-analysis. In Neurogastroenterology and Motility (Vol. 31, Issue 7). Blackwell Publishing Ltd. https://doi.org/10.1111/nmo.13548
  42. Vespa, E., Pellegatta, G., Chandrasekar, V. T., Spadaccini, M., Patel, H., Maselli, R., Galtieri, P. A., Carlani, E., Sharma, P., Hassan, C., & Repici, A. (2023). Long-term outcomes of peroral endoscopic myotomy for achalasia: a systematic review and meta-analysis. In Endoscopy (Vol. 55, Issue 2, pp. 167–175). Georg Thieme Verlag. https://doi.org/10.1055/a-1894-0147
  43. Walzer, N., & Hirano, I. (2008). Achalasia. In Gastroenterology Clinics of North America (Vol. 37, Issue 4, pp. 807–825). https://doi.org/10.1016/j.gtc.2008.09.002
  44. Zhong, C., Tan, S., Ren, Y., Lü, M., Peng, Y., Fu, X., & Tang, X. (2020). Quality of life following peroral endoscopic myotomy for esophageal achalasia: A systematic review and meta-analysis. In Annals of Thoracic and Cardiovascular Surgery (Vol. 26, Issue 3, pp. 113–124). Japanese Association for Coronary Artery Surgery. https://doi.org/10.5761/atcs.ra.19-00273